These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 5916746)
21. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog. Buyniski JP; Smith ML; Bierwagen ME Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236 [No Abstract] [Full Text] [Related]
22. [Hallucinogenic drugs and the psychopharmacology of the conditioned reflex]. Sivadjian J Therapie; 1970; 25(6):1059-66. PubMed ID: 5509533 [No Abstract] [Full Text] [Related]
23. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin. Huang JT; Ho BT Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246 [No Abstract] [Full Text] [Related]
24. Failure of N,N-dimethyltryptamine to evoke tolerance in cats. Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415 [No Abstract] [Full Text] [Related]
27. Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats. Domino EF; Bartolini A Neuropharmacology; 1972 Sep; 11(5):703-13. PubMed ID: 4670597 [No Abstract] [Full Text] [Related]
28. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle. Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434 [TBL] [Abstract][Full Text] [Related]
29. Scratching response induced in mice by mescaline and related amphetamine derivatives. Kulkarni AS Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133 [No Abstract] [Full Text] [Related]
31. Behavioural actions of some substituted amphetamines. Buxton DA Prog Brain Res; 1972; 36():171-81. PubMed ID: 4644027 [No Abstract] [Full Text] [Related]
32. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine. Hill HE; Bell EC; Wikler A Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238 [No Abstract] [Full Text] [Related]
33. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism. Tonge SR; Leonard BE Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826 [No Abstract] [Full Text] [Related]
34. Psychotomimetic agents. Cohen S Annu Rev Pharmacol; 1967; 7():301-18. PubMed ID: 5337083 [No Abstract] [Full Text] [Related]
35. Effects of psychodysleptics on aggressive behavior of animals. Uyeno ET Mod Probl Pharmacopsychiatry; 1978; 13():103-13. PubMed ID: 415228 [No Abstract] [Full Text] [Related]
36. A comparative behavioral study of ditran and LSD in mice, rats, and dogs. Cohen M; Wakeley H Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):316-26. PubMed ID: 5684262 [No Abstract] [Full Text] [Related]
37. PMA deaths in Ontario. Cimbura G Can Med Assoc J; 1974 Jun; 110(11):1263-7. PubMed ID: 4834431 [TBL] [Abstract][Full Text] [Related]
38. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)]. Votava Z; Podvalová I; Vojtĕchovský M Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083 [No Abstract] [Full Text] [Related]